Evidence map›Paper›PMID 37070125›Full record

ArticleInfection and drug resistance2023

Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in

Arunima Goswami, Tirthankar Koley, Madhan Vishal Rajan, Pathak Madhuri, Neelam Upadhyay, Uddipan Das, Manoj Kumar, Abdul Samath Ethayathulla, Gururao Hariprasad

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Arunima GoswamiDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Tirthankar KoleyDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Madhan Vishal RajanDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.ORCID 0000-0001-9374-898X
Pathak MadhuriDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Neelam UpadhyayDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.ORCID 0000-0003-0510-0812
Uddipan DasDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Manoj KumarDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Abdul Samath EthayathullaDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Gururao HariprasadDepartment of Biophysics, All India Institute of Medical Sciences, New Delhi, 110029, India.ORCID 0000-0003-1179-2464
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Leishmaniasis, Chagas disease, and sleeping sickness are caused by protozoa Methods: PAF-AH sequences were retrieved from UniProt and aligned using Clustal Omega. Homologous models of parasitic proteins were built based on crystal structure of human PAF-AH and validated using PROCHECK server. Volumes of substrate-binding channel were calculated using the ProteinsPlus program. High throughput virtual screening using Glide program in Schrodinger was done with ZINC drug library against parasitic PAF-AH enzymes. Complexes with best hits were energy-minimized and subjected to 100 ns molecular dynamic simulation and analyzed. Results: PAF-AH enzyme sequences from protozoa Conclusion: Structures of PAF-AH from protozoan parasites and humans belong to the same family of enzymes and have a similar three-dimensional fold. However, they show subtle variations in residue composition, secondary structure composition, substrate-binding channel volume, and conformational stability. These differences result in certain specific molecules being potent inhibitors of the target enzymes while simultaneously having weaker binding to human homologue.

Indexed as

Chagas diseasedrug efficacydrug targetLeishmania donovanileishmaniasisplatelet activating factor acetyl hydrolasepotent inhibitorprotozoasleeping sicknessTrypanosoma bruceiTrypanosoma cruzi

Identifiers

PMID37070125
PMCPMC10105589
OpenAlexW4363672858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.